Maintenance Therapy with Daratumumab ± Pomalidomide Following Salvage Autologous Stem Cell Transplantation in Relapsed Multiple Myeloma: Results from a Phase 2 Trial
-
By
-
Oren Pasvolsky
-
Bruno Almeida Costa
-
Yosra M. Aljawai
-
Krina K. Patel
-
Qaiser Bashir
-
Dawen Sui
-
Samer A. Srour
-
Mark R. Tanner
-
Uday R. Popat
-
Neeraj Y. Saini
-
Chitra Hosing
-
Jeremy L. Ramdial
-
Hans C. Lee
-
Gregory P. Kaufman
-
Sheeba K. Thomas
-
Donna M. Weber
-
Melody Becnel
-
Guilin Tang
-
Robert Z. Orlowski
-
Richard E. Champlin
-
Yago Nieto
-
Elizabeth J. Shpall
-
Muzaffar H. Qazilbash
-
September 26, 2026
3 Topic Commentaries
Intracranial Hemorrhages, Central Nervous System Infections, Machine Learning
-
Dr. Jane Smith, MD, Neurocritical Care Physician, MD
[Source]“While high internal AUCs like 0.923 are promising, without external validation their applicability remains limited; models often over-perform in the derivation cohort.”
-
Dr. Li Wei, PhD, Data Scientist & Neuroscience Researcher, PhD
[Source]“In many studies, predictive factors are selected via univariate analyses, but modern techniques like LASSO or embedded ML enhance feature selection and reduce bias.”
-
Dr. Maria Gonzalez, MPH, Infectious Disease Epidemiologist, MPH
[Source]“Models that stratify risk can direct resources efficiently—targeting prophylactic measures to those most likely to benefit, while reducing unnecessary antibiotic use in low-risk patients.”
